| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
 |
|
Site Navigation
| ALS News & Research For postings of news or research links and articles related to ALS |
advertisement
| Reply |
|
|
Thread Tools | Display Modes |
|
|
| ALS News & Research For postings of news or research links and articles related to ALS |
| Reply |
|
|
Thread Tools | Display Modes |
10-19-2016, 09:04 AM
|
#1 | |||
|
||||
|
Grand Magnate
|
Cytokinetics Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension Clinical Trial Of Tirasemtiv
Cytokinetics Announces First Patient Enrolled In VIGOR-ALS An Open-Label Extension Clinical Trial Of Tirasemtiv |
|||
|
 Reply With Quote
|
|
10-21-2016, 08:48 AM
|
#2 | |||
|
||||
|
Grand Magnate
|
First Patient Enrolled in Extension Trial for Tirasemtiv to Treat ALS
1st Patient Enrolled in ALS Extension Trial Evaluating Tirasemtiv |
|||
|
|
Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot | Parkinson's Disease | |||
| IPX066 Open Label Extension Study | Parkinson's Disease Clinical Trials | |||
| Teriflunomide: results of an open-label 144-week extension study | Multiple Sclerosis | |||
Cytokinetics Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension C
First Patient Enrolled in Extension Trial for Tirasemtiv to Treat ALS
Linear Mode
